Investment Map: Funding in Your State
The Antimicrobial Resistance (AR) Investment Map showcases CDC activities in the U.S. and abroad to combat antimicrobial resistance. Users can get printable global-, state-, and city-specific fact sheets that describe how CDC is investing directly in the response to antimicrobial resistance at each level.
Through these investments, CDC is transforming how the nation and world combat antimicrobial resistance. For example, CDC is
- Equipping all states and several territories and large cities with lab expertise through CDC’s AR Lab Network and on-the-ground experts to contain outbreaks of resistant germs
- Improving antibiotic and antifungal use across healthcare and veterinary settings globally
- Enhancing detection and tracking of antimicrobial-resistant pathogens for local prevention of healthcare-associated, foodborne, and community threats such as drug-resistant tuberculosis, ESBL-producing Enterobacterales, Candida auris, and gonorrhea
- Spurring innovation through research investments using a One Health approach to identify and implement new ways to combat antimicrobial resistance globally
- Informing the development of new drugs and diagnostics by sharing isolates (pure samples of a germ) and CDC sequencing data
- Supporting partners through the Global AR Lab & Response Network to detect and respond to AR threats across One Health
The map currently shows fiscal year 2023 extramural funds that support CDC’s antimicrobial resistance activities. CDC distributed the largest extramural portion of funding to support all 50 state health departments, several local health departments, and Puerto Rico, Guam, and the U.S. Virgin Islands. The map also includes fact sheets highlighting CDC’s innovation work with partners to combat antimicrobial resistance. The information is updated yearly.
